Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
McFarlane Files Updated Mineral Resource Estimate on Juby Gold Project
-
NOMAD POWER SOLUTIONS ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS
-
Electra Reports Quarterly Update on Capital Markets Activity
-
Provident Financial Services, Inc. Schedules Third Quarter Earnings Conference Call
-
Urban Decay Turns Canter’s Deli Into a One-Night-Only Underground Rave for Its Dirty 30
-
Marfrig Global Foods S.A., through its subsidiary NBM US Holdings, Inc., announces termination of offer to purchase for cash any and all outstanding 6.625% Senior Notes due 2029
-
Traini Partners with TECNO to Bring Native Pet Emotion Translation to Smartphones
-
Chilwa Announces Closing of US$3.5 Million Offering
-
First Hawaiian to Report Third Quarter 2026 Financial Results on October 23, 2026
-
Novo provides update on the denecimig Biologics License Application (BLA) in the US
-
iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026
-
Form 8.3 - Ashtead Technology Holdings plc
-
AtlasClear Holdings Announces Long-Term Stock Option Awards to Support Leadership Retention and Shareholder Alignment
-
Mineralys Therapeutics Announces Presentation of New Lorundrostat Data at the American Society of Nephrology (ASN) Kidney Week 2026
-
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
National Healthcare Properties Announces Conversion of Class A Common Stock into Common Stock
-
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Catheter Precision to Change its Name and Ticker Symbol to Flyte Aviation and “VJET” and Effect 1-for-10 Reverse Stock Split, Monday, October 5, at Market Open
-
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Sood Center for Aesthetic and Plastic Surgery Introduces New Plastic Surgeon, Dr. Marc Gorvet
-
pMD® Completes Annual SOC 2® Type II and HIPAA Security Audits
-
Southport Acquisition Corp. II Announces Completion of Its Initial Public Offering
-
PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Rush Enterprises, Inc. Conference Call Advisory for Third Quarter 2026 Earnings Call
-
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
-
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.0833 per Share
-
Covenant Logistics Group, Inc. Announces Timing of Third Quarter Earnings Release and Conference Call
-
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Spyre Therapeutics Announces Grants of Inducement Awards
-
Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028
-
SEALSQ’s Sister Company, WISeSat.Space, Completes Business Combination with Columbus Acquisition Corporation
-
Safe Bulkers, Inc. Declares Quarterly Dividend on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares; 8.00% Series D Cumulative Redeemable Perpetual Preferred Shares
-
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
WISeQey’s Subsidiary WISeSat.Space, a Space Technology Company, Completes Business Combination with Columbus Acquisition Corporation
-
Pasqal Appoints Roger L. Chuchen as Head of Investor Relations
-
The Women’s Centre of Halton Celebrates $76,000 OTF Grant from Ontario Government for Tech and Cybersecurity Upgrades
-
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Teknova and Pluristyx Announce FDA Drug Master File for the PluriFreeze™ Cryopreservation System
-
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Remittix Unveils BINANCE500 Purchase Bonuses as Solana Price Prediction Revisits $200 and Worldcoin (WLD) Sees peaqOS Adopt World ID for Physical AI
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)


